Recent scaffold-based tissue engineering approaches in premature ovarian failure treatment

IF 3.1 3区生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Journal of Tissue Engineering and Regenerative Medicine Pub Date : 2022-05-05 DOI:10.1002/term.3306

Tayyebeh Zivari-Ghader, Sanam Dolati, Amir Mehdizadeh, Soodabeh Davaran, Mohammad Reza Rashidi, Mehdi Yousefi

引用次数: 2

Abstract

Recently, tissue engineering and regenerative medicine have received significant attention with outstanding advances. The main scope of this technology is to recover the damaged tissues and organs or to maintain and improve their function. One of the essential fields in tissue engineering is scaffold designing and construction, playing an integral role in damaged tissues reconstruction and repair. However, premature ovarian failure (POF) is a disorder causing many medical and psychological problems in women. POF treatment using tissue engineering and various scaffold has recently made tremendous and promising progress. Due to the importance of the subject, we have summarized the recently examined scaffolds in the treatment of POF in this review.

查看原文本刊更多论文

近期基于支架的组织工程技术在卵巢早衰治疗中的应用

近年来，组织工程和再生医学备受关注，取得了突出的进展。这项技术的主要范围是恢复受损的组织和器官或维持和改善其功能。支架的设计与构建是组织工程的核心领域之一，在损伤组织的重建与修复中起着不可或缺的作用。然而，卵巢早衰(POF)是一种导致女性许多医学和心理问题的疾病。近年来，利用组织工程和各种支架治疗POF取得了巨大的进展。鉴于这一课题的重要性，我们在本文中总结了近年来研究的支架在治疗POF中的应用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Tissue Engineering and Regenerative Medicine 生物-工程：生物医学

CiteScore

7.50

自引率

3.00%

发文量

审稿时长

4-8 weeks

期刊介绍： Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed research papers, reviews, clinical case reports, perspectives, and short communications on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs. The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership.